About Index Trending news
Analyze
Top 50 Pricing
Envisia Therapeutics

Envisia Therapeutics

Work at Envisia Therapeutics? Add yourself to this profile

Envisia Therapeutics

Envisia Therapeutics is a privately held #biotech company leveraging its unique PRINT® technology to develop novel, sustained-release ocular therapies

Elsewhere

Alexa global traffic share

Twitter followers

Latest funding
Venture capital (Series A)
$16,500,000
Employees

Team size

10+
Locations
HQ
Headquarters
$16,500,000 Venture capital (Series A)
FinSMEs

Envisia Therapeutics Raises $16.5M in Series A Funding